Auna SA (AUNA)

LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (“Auna” or the “Company”) (NYSE: AUNA), a Latin American healthcare company with operations in Mexico, Peru and Colombia, announced today the filing of its Annua...

Auna achieved strong 2024 results with 11% revenue growth and 20% EBITDA growth, driven by successful operations in Peru and expansion efforts in Mexico. Mexico's market potential is significant, with...

Here is how Auna S.A. (AUNA) and Coya Therapeutics, Inc. (COYA) have performed compared to their sector so far this year.

LUXEMBOURG--(BUSINESS WIRE)--Auna (NYSE: AUNA) (“Auna” or the “Company”), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, today announced financial result...

Here is how Auna S.A. (AUNA) and BioMarin Pharmaceutical (BMRN) have performed compared to their sector so far this year.

The mean of analysts' price targets for Auna S.A. (AUNA) points to a 39.3% upside in the stock.

In January, Seeking Alpha welcomed 29 new analysts. This article introduces them and showcases some of their top picks. Analysts highlighted include The Conservative Investor recommending Dassault Avi...

LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or “the Company”), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced to...

Auna is a leading player in the Spanish-speaking Latin America medical industry, focusing particularly on high-complexity diseases, such as cancer. Most SSLA have a highly fragmented and underserved h...